KBL Merger
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KBL Merger and buy or sell other stocks, options, and ETFs commission-free!About KBLM
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J.
CEOJim N. Woody, MD, PhD
CEOJim N. Woody, MD, PhD
Employees4
Employees4
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2016
Founded2016
Employees4
Employees4
KBLM Key Statistics
Market cap1.90M
Market cap1.90M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume105.36K
Average volume105.36K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$27.93
52 Week high$27.93
52 Week low$1.33
52 Week low$1.33